Patents by Inventor Bo S. Jensen

Bo S. Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for screening compounds for activity in treating an osteoclast related bone disease
    Publication number: 20040224881
    Abstract: The present invention relates to methods for screening and identifying compounds which block chloride channels of the CIC family. In addition, the present invention relates to the use of chloride channel blockers of the CIC family for the treatment, prevention or alleviation of osteoclast related bone diseases.
    Type: Application
    Filed: July 18, 2003
    Publication date: November 11, 2004
    Inventors: Anne Marie Heegaard, Michael T. Engsig, Lars S. Madsen, Bo S. Jensen, Palle Christophersen, Martin Stahlhut, Morten A. Karsdal
  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Patent number: 6545028
    Abstract: This invention relates to treatment or alleviation of a disease, condition or disorder selected from inflammatory bowel disease, Chron's disease, colitis ulcerosa, Coeliac disease, dermatitis herpetiformis, dermatomyositis, enteritis allergia, erytherma nodosum leprosum, ileitis regionalis, psoriasis, purpura, scleritis or scleroderma by administering to a living body certain imidazole, triazole, or 1,4-dihydropyridine derivatives.
    Type: Grant
    Filed: April 14, 2000
    Date of Patent: April 8, 2003
    Assignee: NeuroSearch A/S
    Inventors: Bo S. Jensen, Søren-Peter Olsen, Tino D. Jørgensen, Dorte Strøbæk, Palle Christophersen, Niels Ødum
  • Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
    Publication number: 20020119989
    Abstract: The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca), and the use of such compounds for the treatment or alleviation of diseases or conditions relating to immune dysfunction. Moreover, the invention relates to a method of screening a chemical compound for inhibitory activity on an intermediate conductance Ca 2+ activated potassium channel (IK Ca).
    Type: Application
    Filed: April 14, 2000
    Publication date: August 29, 2002
    Inventors: Bo S. Jensen, Soren-Peter Olsen, Tino D. Jorgensen, Dorte Strobaek, Palle Christophersen